Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-10-29 20:32:34
Reporting Period:
Accepted Time:
2019-10-29 20:32:34
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1733413 Tff Pharmaceuticals Inc. TFFP () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204059 H Randy Thurman 2600 Via Fortuna, Suite 360
Austin TX 78746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-25 5,000 $5.00 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Acquisiton 2019-10-29 43,794 $0.00 43,794 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
135,806 2029-10-29 No 4 A Direct
  1. The shares of common stock purchased in the Issuer's initial public offering.
  2. 25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.